Company / Operating Margin
Idexx Laboratories Operating Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
31.6%
FY2025
5-year range
26.7% / 31.6%
FY2021-FY2025
Trend
+9.2%
vs FY2024
Sector context
#3 of 143
Health Care
What the data says
Among 143 Health Care companies, Idexx Laboratories is in the top 2% for operating margin. Operating Margin has fluctuated over the past 10 years, ranging from 19.7% in FY2016 to 31.6% in FY2025.
Based on SEC 10-K filings.
31.6% in FY2025 with a 5-year CAGR of +5.9%. Ranks 3rd among 143 companies in Health Care.
Improved from 30.0% to 31.6% over the past 2 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- +4.9pp
- 5-Year Change
- +5.9pp
- 10-Year Change
- -
Sector benchmark
Top 2% in Health CareTop 2% of 143This company 31.6% Sector average -295.2%
▼
+110.7% above sector average
Key checks
Key Insights
- In FY2025, operating margin increased 9.2% year-over-year.
- Currently 326.8pp above the Health Care sector average.
- Lowest operating margin in the period was in FY2016.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 4.60 (safe zone, above 2.9 threshold)
- Strong profit margin: 24.6%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 65.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 31.6% | +9.2% |
| FY2024 | 28.9% | -3.4% |
| FY2023 | 30.0% | +12.3% |
| FY2022 | 26.7% | -7.9% |
| FY2021 | 29.0% | +13.0% |
| FY2020 | 25.7% | +11.7% |
| FY2019 | 23.0% | +3.5% |
| FY2018 | 22.2% | +5.8% |
| FY2017 | 21.0% | +6.3% |
| FY2016 | 19.7% | +5.4% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026